CD4 and immunodeficiency disease: This is particularly important since IGRA based on the enzyme-linked immunospot (ELISPOT) technique appear not to lose sensitivity at lower CD4 counts [29,30] although the impact of progressive HIV-related immunodeficiency on IGRA accuracy is still under study.